Riyaz Shah, MBBS, PhD
Enriched profileConsultant Medical Oncologist · Maidstone and Tunbridge Wells NHS Trust
Riyaz Shah is Consultant Medical Oncologist at Maidstone and Tunbridge Wells NHS Trust. OpenAlex indexes 89 publications with 8,920 citations (h-index 24); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.
Data verified 8 Nov 2026
Overview
Updated 14 Nov 2026
Riyaz Shah is Consultant Medical Oncologist at Maidstone and Tunbridge Wells NHS Trust. The public record shows 89 publications with 8,920 citations (h-index 24), centered on Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, HER2/EGFR in Cancer Research. It also documents an investigator role on 3 registered clinical trials.
- Most recent indexed publication: 2021 · Drugs - real world outcomes
- Top research focus: Lung Cancer Treatments and Mutations
- 3 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 14 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. 1 in PubMed. Counts exclude supporting files.
Citations across these publications.
H-index from these publications. i10-index 36.
Clinical & industry
trials, payments and federal fundingNot shown. No U.S. clinical registration on file.
Federally funded research awards.
This is a research profile, built on the published record. There's no U.S. clinical registration (NPI) on file, so facts that hang off one (clinical specialty, industry payments) aren't shown. We'd rather leave a gap than guess. Why? →
Contact
No public contact details on file. Research profiles have no U.S. clinical registration, so there's no federal registry record to draw an address or phone from. Why? →
Clinical trials
Updated 8 Nov 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Sponsor: Nuvalent Inc.
- Hemithoracic Irradiation With Proton Therapy in Malignant Pleural Mesothelioma
Sponsor: University College, London
- Mesothelioma and Radical Surgery 2
Sponsor: Royal Brompton & Harefield NHS Foundation Trust
Industry payments
Not shown. This person has no U.S. clinical registration (NPI) on file, so we can't reliably tie industry payments reported to CMS to them. We'd rather leave a gap than guess. Why? →
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 8 Nov 2026
18 congress contributions (2005–2026) across AACR, ASCO, ESMO, IASLC per OpenAlex. The most recent:
- Abstract 7147: Ultra-high throughput single-nuclei RNAs sequencing of malignant pleural mesothelioma samples in the BEAT-MESO clinical trial
AACR Annual Meeting
AACR2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 8 Nov 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Background & recognition
Updated 8 Nov 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mtw.nhs.uk ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mtw.nhs.uk ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mtw.nhs.uk ↗
Editorial & leadership roles
journal and society appointments- Steering committee member
British Thoracic Oncology Group
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mtw.nhs.uk ↗ - Clinical advisor
EGFR UK and ALK+UK
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mtw.nhs.uk ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →genesiscare.com ↗
Secondary affiliations
appointments beyond the home institution- GenesisCare (private practice)
Maidstone and London Cromwell Hospital
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →genesiscare.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Rajesh Gupta
Maidstone and Tunbridge Wells NHS Trust
Tamzin Cuming
Maidstone and Tunbridge Wells NHS Trust
Mohamed Elalfy
Maidstone and Tunbridge Wells NHS Trust
David J. Gee
Maidstone and Tunbridge Wells NHS Trust
Marc Ladanyi, MD
Memorial Sloan Kettering Cancer Center
Ignacio Wistuba, MD
Moffitt Cancer Center
Pasi Janne, MD, PhD
Dana-Farber Cancer Institute
John Minna, MD
University of Texas Southwestern Medical Center